264 related articles for article (PubMed ID: 15363905)
1. Pathogenic RNA repeats: an expanding role in genetic disease.
Ranum LP; Day JW
Trends Genet; 2004 Oct; 20(10):506-12. PubMed ID: 15363905
[TBL] [Abstract][Full Text] [Related]
2. Gain of RNA function in pathological cases: Focus on myotonic dystrophy.
Klein AF; Gasnier E; Furling D
Biochimie; 2011 Nov; 93(11):2006-12. PubMed ID: 21763392
[TBL] [Abstract][Full Text] [Related]
3. RNA pathogenesis of the myotonic dystrophies.
Day JW; Ranum LP
Neuromuscul Disord; 2005 Jan; 15(1):5-16. PubMed ID: 15639115
[TBL] [Abstract][Full Text] [Related]
4. RNA-mediated neuromuscular disorders.
Ranum LP; Cooper TA
Annu Rev Neurosci; 2006; 29():259-77. PubMed ID: 16776586
[TBL] [Abstract][Full Text] [Related]
5. Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.
Ranum LP; Day JW
Curr Neurol Neurosci Rep; 2002 Sep; 2(5):465-70. PubMed ID: 12169228
[TBL] [Abstract][Full Text] [Related]
6. [Molecular pathways to myotonic dystrophy].
Ishiura S
Nihon Rinsho; 2005 Mar; 63(3):515-21. PubMed ID: 15773354
[TBL] [Abstract][Full Text] [Related]
7. Dominant non-coding repeat expansions in human disease.
Dick KA; Margolis JM; Day JW; Ranum LPW
Genome Dyn; 2006; 1():67-83. PubMed ID: 18724054
[TBL] [Abstract][Full Text] [Related]
8. [Myotonic dystrophy].
Nanba E
Nihon Rinsho; 2005 Mar; 63(3):429-33. PubMed ID: 15773341
[TBL] [Abstract][Full Text] [Related]
9. Dominantly inherited, non-coding microsatellite expansion disorders.
Ranum LP; Day JW
Curr Opin Genet Dev; 2002 Jun; 12(3):266-71. PubMed ID: 12076668
[TBL] [Abstract][Full Text] [Related]
10. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9.
Liquori CL; Ricker K; Moseley ML; Jacobsen JF; Kress W; Naylor SL; Day JW; Ranum LP
Science; 2001 Aug; 293(5531):864-7. PubMed ID: 11486088
[TBL] [Abstract][Full Text] [Related]
11. [Molecular genetics of myotonic dystrophy--population genetics of the CTG repeat expansion of the MTPK gene].
Yamagata H; Miki T; Ogihara T
Nihon Rinsho; 1997 Dec; 55(12):3205-9. PubMed ID: 9436437
[TBL] [Abstract][Full Text] [Related]
12. Expanding complexity in myotonic dystrophy.
Groenen P; Wieringa B
Bioessays; 1998 Nov; 20(11):901-12. PubMed ID: 9872056
[TBL] [Abstract][Full Text] [Related]
13. Myotonic dystrophy type 1 (DM1): a triplet repeat expansion disorder.
Kumar A; Agarwal S; Agarwal D; Phadke SR
Gene; 2013 Jun; 522(2):226-30. PubMed ID: 23570879
[TBL] [Abstract][Full Text] [Related]
14. Molecular therapy in myotonic dystrophy: focus on RNA gain-of-function.
Mulders SA; van Engelen BG; Wieringa B; Wansink DG
Hum Mol Genet; 2010 Apr; 19(R1):R90-7. PubMed ID: 20406734
[TBL] [Abstract][Full Text] [Related]
15. DM2 CCTG*CAGG repeats are crossover hotspots that are more prone to expansions than the DM1 CTG*CAG repeats in Escherichia coli.
Dere R; Wells RD
J Mol Biol; 2006 Jun; 360(1):21-36. PubMed ID: 16753177
[TBL] [Abstract][Full Text] [Related]
16. Myotonic dystrophy: RNA pathogenesis comes into focus.
Ranum LP; Day JW
Am J Hum Genet; 2004 May; 74(5):793-804. PubMed ID: 15065017
[TBL] [Abstract][Full Text] [Related]
17. Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2.
Cardani R; Mancinelli E; Rotondo G; Sansone V; Meola G
Eur J Histochem; 2006; 50(3):177-82. PubMed ID: 16920640
[TBL] [Abstract][Full Text] [Related]
18. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
Cho DH; Tapscott SJ
Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
[TBL] [Abstract][Full Text] [Related]
19. Myotonic dystrophies.
Huang CC; Kuo HC
Chang Gung Med J; 2005 Aug; 28(8):517-26. PubMed ID: 16265841
[TBL] [Abstract][Full Text] [Related]
20. Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP.
Klesert TR; Otten AD; Bird TD; Tapscott SJ
Nat Genet; 1997 Aug; 16(4):402-6. PubMed ID: 9241282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
